DE SANCTIS, Vincenzo et al. The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network: Oral glucose-lowering agents (GLAs) in β-thalassemia patients. Acta Biomedica Atenei Parmensis, Fidenza, Italy, v. 93, n. 2, p. e2022162, 2022. DOI: 10.23750/abm.v93i2.12056. Disponível em: https://mattioli1885journals.com/index.php/actabiomedica/article/view/12056. Acesso em: 14 may. 2025.